Artículos Científicos

Artículos Científicos

1.Finzel et al. The combined analysis of solid and liquid biopsies provides additional clinical information to improve patient care J Cancer Metastasis Treat 2018;4:21

2.Laes et al. The clinical impact of using complex molecular profiling strategies in routine oncology practice Oncotarget, 2018, Vol. 9, (No. 29), pp: 20282-20293

3.Lih et al. Analytical Validation of the Next-Generation Sequencing Assay for a Nationwide Signal-Finding Clinical Trial: Molecular Analysis for Therapy Choice Clinical Trial. J Mol Diagn. 2017 Mar;19(2):313-327

4.Siravegna et al Integrating liquid biopsies into the management of cancer. Nat Rev Clin Oncol. 2017 Sep;14(9):531-548

5.Rothe et al. “Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer.” Annals of Oncology 25.10 (2014): 1959-1965

6.Lanman et al. “Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA.” PloS One 10.10 (2015) 10.1371/journal.pone.0140712

7.Vandeputte et al. Circulating tumor DNA in early response assessment and monitoring of advanced colorectal cancer treated with a multi-kinase inhibitor Oncotarget. 2018 Apr 3;9(25):17756-17769

8.Prat et al. “Prediction of Response to Neoadjuvant Chemotherapy Using Core Needle Biopsy Samples with the Prosigna Assay.” Clinical Cancer Research, 2015 10.1158/1078-043.

9.Trafalis et al. Evidence for Efficacy of Treatment With the Anti-PD-1 Mab Nivolumab in Radiation and Multichemorefractory Advanced Penile Squamous Cell Carcinoma J Immunother. 2018 Apr 10. doi: 10.1097

10.Gonget et al. Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations Journal for ImmunoTherapy of Cancer (2018) 6:8

11.Ramírez de Olano et al. A Case Report Demonstrating the Potential Clinical Benefit of Exhaustive Molecular Profiling in an Aggressive Muscle-Invasive High-Grade Metastatic Urothelial Carcinoma Case Rep Oncol. 2017 Jun 9;10(2):493-500